Compounds > 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
Page last updated: 2024-09-03

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and 1,2-distearoylphosphatidylethanolamine

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with 1,2-distearoylphosphatidylethanolamine in 1 studies

Compound Research Comparison

Studies
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Trials
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Recent Studies (post-2010)
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Studies
(1,2-distearoylphosphatidylethanolamine)		Trials
(1,2-distearoylphosphatidylethanolamine)		Recent Studies (post-2010) (1,2-distearoylphosphatidylethanolamine)
1174322810143

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anantha, M; Bally, MB; Bregman, I; Ginj, M; Ho, EA; Osooly-Talesh, M; Ramsay, E; Sy, J; Woo, J; Yapp, DT1

Other Studies

1 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and 1,2-distearoylphosphatidylethanolamine

ArticleYear
Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:6

    Topics: Animals; Antineoplastic Agents; Cations; Chemistry, Pharmaceutical; Cholesterol; Dosage Forms; Drug Delivery Systems; Female; Lipids; Liposomes; Mice; Phosphatidylethanolamines; Polyethylene Glycols; Raloxifene Hydrochloride; Tissue Distribution

2010